Adverse events related to biologicals used for patients with multiple sclerosis: a comparison between information originating from regulators and information originating from the scientific community

Background and purpose Clinical decision making is facilitated by healthcare professionals’ and patients’ adequate knowledge of the adverse events. This is especially important for biologicals used for treating multiple sclerosis (MS). So far, little is known about whether different information sour...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of neurology 2020-07, Vol.27 (7), p.1250-1256
Hauptverfasser:	Minnema, L. A., Giezen, T. J., Egberts, T. C. G., Leufkens, H. G. M., Gardarsdottir, H.
Format:	Artikel
Sprache:	eng
Schlagworte:	adverse events biologicals Clinical trials Decision making Discordance Documents European Public Assessment Report Health services Information sources Multiple Sclerosis Original Patients Regulators Scientific papers scientific publication
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!